Clinical Trial: Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: Lung Cancer
Study Type: INTERVENTIONAL
Official Title: Phase I Trial of Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer
Brief Summary:
The purpose of this study is to examine the use of hypofractionated accelerated radiation therapy (HART) to treat locally advanced lung cancer.Depending on the location and size of the tumor.
Read more